{
  "docId": "019dd923-622b-71dc-a6da-c134db96b8a0",
  "docSlug": "fc8c1213a5a9",
  "documentTitle": "Perrigo Company plc (PRGO)",
  "authorId": "03_Starboard_Value",
  "authorName": "Jeffrey C. Smith",
  "documentKindSlug": "shareholder-letter",
  "documentKindLabel": "Shareholder letter",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2016-09-12 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.77272725,
  "pageNumber": 3,
  "pageCount": 7,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "balanced",
  "nDataPoints": 13,
  "notes": "The slide uses a bar chart to visualize margin erosion in the BCH segment following the Omega acquisition.",
  "elementsJson": [
    "paragraph",
    "bar_chart_vertical",
    "callout_box"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622b-71dc-a6da-c134db96b8a0/3",
  "deckHref": "/decks/019dd923-622b-71dc-a6da-c134db96b8a0",
  "deckJsonHref": "/decks/019dd923-622b-71dc-a6da-c134db96b8a0.json",
  "deckAnchorHref": "/decks/019dd923-622b-71dc-a6da-c134db96b8a0#slide-3",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "We fail to see why this should be the case – especially given the significant synergies between CHC and BCH – and believe that this illustrates a clear lack of focus and execution in the core business.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-78b7-702e-9634-2d7a6a0f4488",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.8,
        "x": 0.1,
        "y": 0.68
      },
      "kind": "chart",
      "text": "Branded Consumer Healthcare – Adj. Operating Margin Deterioration",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "25556521-8796-451e-8316-3d9283dd6be3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Adj. Operating Margin: 14.9%",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd953-78b7-702e-9634-32514d7e771f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.8,
        "x": 0.1,
        "y": 0.12
      },
      "kind": "paragraph",
      "text": "In addition to Perrigo's core OTC businesses, Perrigo also owns several valuable, but non-core assets.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "123cae72-6aaa-4c26-944f-13d255d17ad6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.5,
        "x": 0.1,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "Source: Company Filings; Omega Pharma Invest N.V. company filings; Starboard Value estimates",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0029e111-f7ec-4a00-aaa5-74f382b34860",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.1,
        "y": 0.05
      },
      "kind": "title",
      "text": "Non-Core Assets & Core Business Opportunity",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d8f760a2-a5c6-466a-ba14-34fd77fdb6cb",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "fraud-exposure",
      "slug": null,
      "matchId": "1951a96b-3326-4518-81dc-4feaab004f95",
      "evidence": "The slide highlights declining margins and poor execution to argue for management change and asset divestiture.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}